All news

TransMedics holds consensus Hold with

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

TransMedics Group (NASDAQ:TMDX) carries a consensus "Hold" rating from brokerages, with an average 12-month price target of

Read original source

TMDX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.